Behçet’s disease has no definitive blood test, biopsy, or genetic marker that clinches the diagnosis. Instead, doctors rely on clinical criteria sets that tally specific combinations of symptoms. The two most widely used frameworks are the 1990 International Study Group (ISG) criteria, which require recurrent oral ulcers plus at least two other characteristic features, and the revised 2014 International Criteria for Behçet’s Disease (ICBD), which use a point-scoring system and cast a wider net. Both attempt to solve the same problem: identifying a disease that can look like a dozen other conditions and that varies dramatically from patient to patient.
The ISG Criteria and Why Oral Ulcers Are Central
The ISG criteria, published in 1990, remain the most commonly referenced diagnostic framework worldwide. They consist of five items, and the first one is non-negotiable: recurrent oral ulceration, observed by a clinician or reliably reported by the patient, occurring at least three times in a twelve-month period. Without that, the ISG criteria cannot be met. In addition to oral ulcers, a patient needs at least two of the following four features: recurrent genital ulcers, eye inflammation (uveitis or retinal vasculitis), defined skin lesions (such as erythema nodosum-like nodules or pseudofolliculitis), or a positive pathergy test.1Clinical and Experimental Immunology. Clinical Immunology Review Series: An approach to the patient with recurrent orogenital ulceration, including Behçet’s syndrome
The strength of the ISG set is its specificity, meaning it rarely labels someone as having Behçet’s when they don’t. When tested across patient groups in China, Iran, and Germany, specificity ranged from about 89% to over 99%.2PubMed Central. Diagnosis/Classification Criteria for Behcet’s Disease The tradeoff is sensitivity. In the same studies, the ISG criteria caught only about 65% to 84% of confirmed cases, depending on the population. That means a meaningful share of people who genuinely have Behçet’s don’t meet the ISG bar, particularly those who present with serious organ involvement but whose mucocutaneous symptoms are mild or slow to develop.
The requirement that oral ulcers be present has drawn criticism over the years. Some patients develop severe vascular or neurological disease years before oral ulcers appear, or in rare cases never develop prominent oral ulcers at all.3Yonsei Medical Journal. Diagnostic criteria of Behçet’s disease: problems and suggestions For these patients, the ISG criteria create a diagnostic dead end.
The ICBD 2014 Point System
The revised International Criteria for Behçet’s Disease, finalized in 2014, replaced the mandatory-oral-ulcer approach with a weighted scoring system. Each manifestation earns points:
- Oral aphthosis: 2 points
- Genital aphthosis: 2 points
- Ocular lesions: 2 points
- Skin lesions: 1 point
- Neurological involvement: 1 point
- Vascular manifestations: 1 point
- Positive pathergy test: 1 point (optional, added when performed)
A score of four or more classifies the patient as having Behçet’s disease.4PubMed. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria The key difference from the ISG set is that oral ulcers are no longer mandatory. A patient with genital ulcers, eye inflammation, and a vascular event (2 + 2 + 1 = 5 points) could meet the ICBD criteria without any oral involvement.
This change was deliberate. The earlier version of the ICBD, published in 2006, assigned only 1 point to oral ulcers. The 2014 revision bumped oral aphthosis up to 2 points and added neurological involvement as a scoreable item, reflecting growing recognition that Behçet’s frequently strikes the central nervous system.5IntechOpen. The History and Diagnosis of Behçet’s Disease – Section: The diagnosis and classification criteria of Behçet’s disease The threshold was also raised from 3 to 4 points to maintain reasonable specificity.
The ICBD criteria are more sensitive than the ISG set, catching a higher proportion of true cases, particularly in people with early or incomplete disease. But that broader net comes with a real risk: some patients with other inflammatory conditions, such as spondyloarthritis, can accumulate enough points to meet the ICBD threshold, leading to overdiagnosis.6PubMed Central. Update on the Diagnosis of Behçet’s Disease This is why many clinicians use both sets together rather than relying on one alone.
What Counts as Ocular Involvement
Eye disease is one of the most serious features of Behçet’s, and it carries heavy weight in both criteria sets. The forms of eye inflammation that qualify include anterior uveitis (inflammation in the front chamber of the eye), combined anterior chamber and vitreous inflammation, posterior uveitis with retinal vasculitis or focal infiltrates, and panuveitis with retinal vasculitis or focal infiltrates.7PubMed Central. Classification criteria for Behçet Disease Uveitis Not every type of eye inflammation counts. Specialized diagnostic algorithms for Behçet’s uveitis specifically look for features like superficial retinal infiltrates and occlusive retinal vasculitis, while noting that granulomatous inflammation and choroiditis actually point away from Behçet’s.8PubMed. An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults
Eye involvement tends to be more common and more severe in men, and it can lead to vision loss if not treated aggressively. The pattern of inflammation in Behçet’s has a characteristic relapsing course, with acute flares that can damage the retina and optic nerve over time. Because the eye findings carry 2 points in the ICBD system, a person with recurrent oral ulcers and a single episode of confirmed Behçet’s-type uveitis already meets the diagnostic threshold.
Genital Ulcers, Skin Lesions, and the Pathergy Test
Genital ulcers are the second most common mucocutaneous feature, reported in roughly 57% to 93% of patients across different populations. They look similar to oral ulcers but tend to be deeper, can be quite painful, and have a tendency to scar. Because of the scarring, even if no active ulcer is present at the time of examination, old scars in the genital area can serve as evidence of past disease activity.9Yonsei Medical Journal. Mucocutaneous Lesions of Behçet’s Disease – Section: Genital ulcers This is a practical tip that matters for diagnosis: a careful physical exam looking for healed scars can fill in gaps when ulcers are not active.
Skin lesions in Behçet’s include erythema nodosum-like nodules (tender, red lumps usually on the shins), pseudofolliculitis (acne-like papules and pustules), and sometimes papulopustular lesions. These earn 1 point in the ICBD system and count as one of the four secondary features in the ISG criteria.
The pathergy test is a simple but unusual procedure: a sterile needle pricks the forearm skin, and the site is examined 24 to 48 hours later. A positive result means a red papule or pustule forms at the puncture site, indicating the exaggerated skin reactivity typical of Behçet’s. The test is highly specific when positive, but its sensitivity is frustratingly low and varies by geography. It tends to be more often positive in patients from Turkey, Iran, and East Asia, and less reliable in Western European and North American patients. Recent research has explored modifying the test by injecting pneumococcal vaccine antigens alongside the needle prick, which pushed sensitivity up to about 80% in patients with active disease while maintaining perfect specificity in one study.10Rheumatology. Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease In the ICBD system, the pathergy test is optional: it adds 1 point when performed and positive, but a diagnosis can be made without it.
When the Disease Hits the Brain or Blood Vessels
One of the most consequential updates in the ICBD criteria was the inclusion of neurological and vascular manifestations, which the ISG criteria ignored entirely. Behçet’s is fundamentally a vasculitis, an inflammation of blood vessels, and vascular disease is one of its most dangerous complications. Venous involvement (deep vein thrombosis, superficial thrombophlebitis) is more common than arterial involvement. When broken down, roughly 85% of vascular events are venous, about 10% are arterial, and 5% involve both.11Radiology and Diagnostic Imaging. Vascular involvement in Behçet’s disease: Imaging features – Section: Involvement of thoracic vessels Pulmonary artery aneurysms, though uncommon, are the most frequent form of pulmonary involvement and can be life-threatening.
Neuro-Behçet’s disease has its own diagnostic framework, the 2014 International Consensus Recommendations (ICR), which combine clinical symptoms with MRI findings and cerebrospinal fluid analysis to classify cases as “definite” or “probable.”12PubMed Central. Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations – Section: International consensus recommendation (ICR) diagnostic criteria of NBD Neurological involvement divides into two broad patterns: parenchymal disease, which affects the brain tissue itself and often presents with headaches, confusion, or focal neurological deficits, and non-parenchymal disease, which typically involves cerebral venous sinus thrombosis.13Clinical and Experimental Immunology. Neuro-Behçet’s disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis – Section: Clinical diagnosis These are very different clinical pictures, and the distinction matters for treatment.
Intestinal Behçet’s and the Crohn’s Disease Puzzle
Gastrointestinal involvement adds another layer of diagnostic complexity, particularly because intestinal Behçet’s and Crohn’s disease can look strikingly similar. Both cause bowel ulcers, abdominal pain, and diarrhea, and patients with either condition may have mouth sores and joint symptoms. Researchers have worked on distinguishing the two through colonoscopy findings. Intestinal Behçet’s typically produces round or oval ulcers, fewer in number, clustered in the ileocecal region, while Crohn’s tends to produce longitudinal ulcers with a more diffuse or segmental distribution, cobblestone-appearing mucosa, and perianal disease.14PubMed. Differential diagnosis of intestinal Behçet’s disease and Crohn’s disease by colonoscopic findings One study using these colonoscopic features correctly classified over 90% of patients.15PubMed Central. Comparison between Intestinal Behçet’s Disease and Crohn’s Disease in Characteristics of Symptom, Endoscopy, and Radiology
The ISG and ICBD criteria were not designed with gastrointestinal Behçet’s in mind, and neither set includes bowel findings as scored items. This means a patient whose disease primarily affects the gut may struggle to meet the formal classification criteria even when the clinical picture is obvious to an experienced specialist.
Diagnosing Behçet’s in Children
Children present a special challenge. Behçet’s disease in pediatric patients can look different from the adult version: symptoms often appear one at a time over years rather than all at once, and the mix of manifestations varies by sex and geography. In one large international cohort of 219 pediatric patients, oral aphthosis was the first symptom in 81% of cases, with an average delay of nearly three years before a second qualifying symptom appeared.16PubMed. Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD Boys were more likely to develop skin, eye, and vascular symptoms, while girls more often developed genital ulcers.
Recognizing that adult criteria did not perform well in children, the PEDBD (PEDiatric Behçet’s Disease) classification was developed, requiring at least three signs from six categories. When all three sets were tested head-to-head against expert classification in a validation study, the ICBD performed best, with sensitivity of 0.79 and specificity of 0.97. The ISG criteria had perfect specificity of 1.00 but caught only half of confirmed pediatric cases. The PEDBD criteria fell in between, with sensitivity of 0.58 and specificity of 0.99.17Rheumatology. Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach None of these sets is clearly superior in children, which underscores how difficult pediatric diagnosis remains.
Why Genetic Testing Is Not Part of the Criteria
The strongest known genetic association with Behçet’s disease is the HLA-B*51 allele, which has been consistently linked to increased risk across many populations. You might expect this to appear somewhere in the criteria, but it doesn’t. The ISG criteria don’t include it, the ICBD criteria don’t include it, and even the Japanese criteria, which list HLA-B*51 as a “reference finding,” assign it no diagnostic weight.18PubMed Central. The association of Behçet’s syndrome with HLA-B51 as understood in 2021 – Section: CLINICAL IMPLICATION OF HLA-B∗51
The reason is straightforward: HLA-B*51 is common in the general population of many countries where Behçet’s is prevalent, and plenty of people carry it without ever developing the disease. Testing positive gives you a somewhat higher risk but tells you almost nothing about whether you currently have Behçet’s. And many confirmed patients are HLA-B*51 negative. A genetic test that misses a large fraction of true cases and flags a large number of healthy people is not useful as a diagnostic criterion.
The Differential Diagnosis Problem
A substantial portion of patients referred to specialist centers with suspected Behçet’s turn out to have something else. In one two-center retrospective analysis, only about 29% of patients referred for possible Behçet’s were classified as “probable” cases. The rest were diagnosed with a range of other conditions, most commonly primary skin diseases (about 28%), chronic pain syndromes (about 13%), eye diseases unrelated to Behçet’s (about 7%), and spondyloarthritis (about 5%).19Rheumatology. When it looks like Behçet’s syndrome but is something else: differential diagnosis of Behçet’s syndrome: a two-centre retrospective analysis This high rate of misreferral reflects how many common conditions can mimic individual features of Behçet’s.
Adding to the complexity, “Behçet-like syndromes” are a recognized phenomenon. These occur when an identifiable underlying condition, such as a genetic autoinflammatory disorder, myelodysplastic syndrome, an infection, or a drug reaction, produces symptoms that look almost identical to Behçet’s. Biopsies are no help in distinguishing the two, because the tissue changes (neutrophilic infiltrates, lymphocytic vasculitis, ulceration) are indistinguishable from those seen in classic Behçet’s.20PubMed Central. Behçet-like Syndromes: A Comprehensive Review – Section: 4. Discussion Diagnosis of a Behçet-like syndrome requires identifying the underlying cause, which is why ruling out other conditions is a critical part of evaluating any suspected Behçet’s case.
Tracking Disease Activity After Diagnosis
The criteria sets described above are designed for classification, meaning to decide whether someone has the disease. They were not designed to measure how active the disease is at any given moment, which is a different problem. Behçet’s is a relapsing-remitting condition, and the same patient may go months without symptoms before a sudden flare of oral ulcers, skin lesions, or eye inflammation.
Researchers have been developing patient-reported outcome measures to track mucocutaneous activity over time. A mucocutaneous activity index tested across multiple centers in Turkey showed promise as a reliable tool for monitoring oral and genital ulcer frequency and skin lesion burden between clinic visits.21Arthritis & Rheumatology. Mucocutaneous Activity Index As a Patient-Reported Outcome Measure in Behcet’s Disease: A Multi-Center Study from Turkey Standardized tracking matters because the pattern of flares, their frequency, and which organs are involved all inform treatment decisions. A patient whose disease is limited to occasional mouth sores will be managed very differently from one with recurrent eye inflammation or vascular events.
For clinicians, the practical challenge is that Behçet’s disease evolves. Someone who initially meets criteria based on oral and genital ulcers may later develop neurological or vascular complications that reframe the severity of the disease entirely. The classification criteria get you in the door, but they don’t tell you what the disease will do next.